← Eichor
Condition: Arterial Thrombosis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Arterial Thrombosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Immune Checkpoint Inhibitor Associated Cardiovascular Adverse Events in Patients With Cancer
Phase N/A · 1 location(s) · Hanneke W. M. van Laarhoven · NCT06519292Electrical Impedance Tomography for Assessment of Pulmonary Hypertension
NA · 1 location(s) · University of Sao Paulo General Hospital · NCT07453017Multi-modal Quantitative Imaging of the Skin
Phase N/A · 3 location(s) · HJN Sverige AB/Neko Health · NCT06989216Study of Predictive Factors Related to Prognosis of Patients With Ischemic Stroke Due to Large-artery Atherosclerosis
Phase N/A · 1 location(s) · Tongji Hospital · NCT04847752Study Regarding the Incidence of Anti-platelet Factor 4-antibodies in Patients Aged 18 to 60 Years With Spontaneous or I
Phase N/A · 2 location(s) · Cardioangiologisches Centrum Bethanien · NCT06650826Registry of Coronary Artery Ill Patients With Platelet Test Results
Phase N/A · 1 location(s) · Action, France · NCT02762162Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
NA · 2 location(s) · University of Tennessee · NCT06374277Bioimpedance Measurement of Abdominal Free Flaps During Arterial and Venous Weaning in Breast Reconstruction
NA · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT05710705Multi-Omics-Based Novel Thrombosis and Bleeding Markers and Risk Model for CHD
Phase N/A · 3 location(s) · Xueyan Zhao · NCT07523880Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
Phase 3 · 9 location(s) · Regeneron Pharmaceuticals · NCT07318610A PMCF Study to Confirm the Performance and Safety of the LeMaitre® TufTex Single Lumen Embolectomy Catheter
NA · 3 location(s) · LeMaitre Vascular · NCT05386277High Coverage CARotid Stenting vs. Medical Management Alone to Prevent EmboliSm From symptomaTic Non-stenotic cARotid Di
Phase N/A · 1 location(s) · Acandis GmbH · NCT07166731Longitudinal Cohort of Thrombosis and Hemostasis Diseases
Phase N/A · 5 location(s) · Peking University People's Hospital · NCT06727669Conversion Therapy With FOLFOX-HAIC Plus Lenvatinib And Tislelizumab For Hepatocellular Carcinoma With Vp3 Portal Vein T
Phase 2 · 1 location(s) · First Hospital of China Medical University · NCT07483359Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS
Phase N/A · 3 location(s) · McMaster University · NCT05646394Thrombus Imaging and Treatment Analytics in Neurology
Phase N/A · 1 location(s) · Chinese PLA General Hospital · NCT05663281Vascular Lab Resource (VLR) Biorepository
Phase N/A · 1 location(s) · The Cleveland Clinic · NCT05628948Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation
Phase 4 · 1 location(s) · Duan Chuanzhi · NCT06308952Copenhagen Mesenteric Stent Study - A Randomized Trial of Stent Versus Covered Stent Treatment for Chronic Mesenteric Is
NA · 1 location(s) · Rigshospitalet, Denmark · NCT05244629Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath
Phase N/A · 1 location(s) · ChromX Health · NCT06528418Acute Stroke of CArotid Artery Bifurcation Origin Treated With Use oF the MicronEt-covered CGUARD (SAFEGUARD-STROKE)
Phase N/A · 1 location(s) · John Paul II Hospital, Krakow · NCT05195658Myocardialbridge Bypass Graft Surgery Efficacy Verification
NA · 1 location(s) · Xi'an International Medical Center Hospital · NCT06857838Translational Immunodiagnostics in Stroke (TrImS)
Phase N/A · 1 location(s) · The University of Hong Kong · NCT05300997Duration of Dual Anti-Platelet Therapy in Chronic Limb Threatening Ischemia After Distal Revascularization
Phase 3 · 1 location(s) · Fondation Hôpital Saint-Joseph · NCT07512960Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease
NA · 2 location(s) · Massachusetts General Hospital · NCT07613840Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT
Phase 2 · 1 location(s) · Second Affiliated Hospital of Guangzhou Medical University · NCT06904183Prospective, Single-Arm, Multicenter Study to Evaluate the Effectiveness and Safety of Endovascular Treatment in Patient
Phase N/A · 11 location(s) · Hospital Universitario Central de Asturias · NCT06201598Perioperative Sintilimab Plus Bevacizumab Biosimilar and TACE-HAIC for HCC Patients With PVTT: A Phase-2 Clinical Trial
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT06031285COMPLEX Registry - a Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting with CompLE
Phase N/A · 1 location(s) · Luzerner Kantonsspital · NCT06075602QL1706 in Combination With Bevacizumab and RALOX HAIC for Hepatocellular Carcinoma With Vp3/4 PVTT
Phase 2 · 1 location(s) · Nanfang Hospital, Southern Medical University · NCT07327788
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.